178 related articles for article (PubMed ID: 32945491)
21. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
[TBL] [Abstract][Full Text] [Related]
22. RUNX2 promotes hepatocellular carcinoma cell migration and invasion by upregulating MMP9 expression.
Wang Q; Yu W; Huang T; Zhu Y; Huang C
Oncol Rep; 2016 Nov; 36(5):2777-2784. PubMed ID: 27666365
[TBL] [Abstract][Full Text] [Related]
23. SMARCC2 combined with c‑Myc inhibits the migration and invasion of glioma cells via modulation of the Wnt/β‑catenin signaling pathway.
Li C; Fei C; Li J; Wu H; Chen L; Roshani R; Li H; Shi L; Song C; Gu J; Lu Y; Zhou Q
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080022
[TBL] [Abstract][Full Text] [Related]
24. Ethyl acetate extract from Jiedu Xiaozheng Yin inhibits the proliferation of human hepatocellular carcinoma cells by suppressing polycomb gene product Bmi1 and Wnt/β-catenin signaling.
Chen XZ; Cao ZY; Li JN; Hu HX; Zhang YQ; Huang YM; Liu ZZ; Hu D; Liao LM; Du J
Oncol Rep; 2014 Dec; 32(6):2710-8. PubMed ID: 25333742
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of the Notch signaling pathway inhibits hepatocellular carcinoma cell invasion by inactivation of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor.
Zhou L; Wang DS; Li QJ; Sun W; Zhang Y; Dou KF
Oncol Rep; 2012 Sep; 28(3):874-82. PubMed ID: 22736202
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA SUMO1P3 promotes hepatocellular carcinoma progression through activating Wnt/β-catenin signalling pathway by targeting miR-320a.
Wu S; Chen S; Lin N; Yang J
J Cell Mol Med; 2020 Mar; 24(5):3108-3116. PubMed ID: 31970876
[TBL] [Abstract][Full Text] [Related]
28. USP3 inhibition is Active Against Chemo-resistant Hepatocellular Carcinoma Anchorage-independent Growth
Xu J; Gui GSW; Yang C; Zhu S; Chen Z; Ma SLB; Yang C; Bu CRL; Zhu Y; Xu W
Curr Mol Med; 2024; 24(5):667-675. PubMed ID: 37921189
[TBL] [Abstract][Full Text] [Related]
29. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression.
Ha TY; Hwang S; Moon KM; Won YJ; Song GW; Kim N; Tak E; Ryoo BY; Hong HN
Anticancer Res; 2015 Apr; 35(4):1967-76. PubMed ID: 25862849
[TBL] [Abstract][Full Text] [Related]
30. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
Sun J; Liu L; Zou H; Yu W
Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
[TBL] [Abstract][Full Text] [Related]
31. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.
Gu W; Li X; Wang J
Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507
[TBL] [Abstract][Full Text] [Related]
32. Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway.
Xu MX; Zhao L; Deng C; Yang L; Wang Y; Guo T; Li L; Lin J; Zhang L
Int J Oncol; 2013 Dec; 43(6):1951-9. PubMed ID: 24064724
[TBL] [Abstract][Full Text] [Related]
33. Synergistic effect of berberine and HMQ1611 impairs cell proliferation and migration by regulating Wnt signaling pathway in hepatocellular carcinoma.
Dai B; Ma Y; Yang T; Fan M; Yu R; Su Q; Wang H; Liu F; Yang C; Zhang Y
Phytother Res; 2019 Mar; 33(3):745-755. PubMed ID: 30565332
[TBL] [Abstract][Full Text] [Related]
34. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
Cao F; Yin LX
Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
[TBL] [Abstract][Full Text] [Related]
35. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of CD44 inhibits proliferation, migration, and invasiveness in hepatocellular carcinoma cells by modulating CXCR4/Wnt/β-Catenin Axis.
Song X; Ding F; Luo W; Tao J; Yang K; Li Q; Zhang Z
Acta Biochim Pol; 2023 Feb; 70(1):117-122. PubMed ID: 36735564
[TBL] [Abstract][Full Text] [Related]
37. Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/β-Catenin Signaling.
Tong Z; Li M; Wang W; Mo P; Yu L; Liu K; Ren W; Li W; Zhang H; Xu J; Yu C
J Biol Chem; 2015 Jul; 290(30):18596-608. PubMed ID: 26082485
[TBL] [Abstract][Full Text] [Related]
38. KIF18B promotes hepatocellular carcinoma progression through activating Wnt/β-catenin-signaling pathway.
Yang B; Wang S; Xie H; Wang C; Gao X; Rong Y; Liu Z; Lu Y
J Cell Physiol; 2020 Oct; 235(10):6507-6514. PubMed ID: 32052444
[TBL] [Abstract][Full Text] [Related]
39. High expression of XRCC5 is associated with metastasis through Wnt signaling pathway and predicts poor prognosis in patients with hepatocellular carcinoma.
Liu ZH; Wang N; Wang FQ; Dong Q; Ding J
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7835-7847. PubMed ID: 31599408
[TBL] [Abstract][Full Text] [Related]
40. 6-C-(E-Phenylethenyl)Naringenin Attenuates the Stemness of Hepatocellular Carcinoma Cells by Suppressing Wnt/β-Catenin Signaling.
Kang Q; Gong J; Wang M; Wang Q; Chen F; Cheng KW
J Agric Food Chem; 2019 Dec; 67(50):13939-13947. PubMed ID: 31769973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
